Literature DB >> 11158161

Fatal pulmonary infection due to multidrug-resistant Mycobacterium abscessus in a patient with cystic fibrosis.

M Sanguinetti1, F Ardito, E Fiscarelli, M La Sorda , P D'Argenio, G Ricciotti, G Fadda.   

Abstract

We report a case of fatal pulmonary infection caused by Mycobacterium abscessus in a young patient with cystic fibrosis, who underwent bipulmonary transplantation after a 1-year history of severe lung disease. Fifteen days after surgery he developed septic fever with progressive deterioration in lung function. M. abscessus, initially isolated from a pleural fluid specimen, was then recovered from repeated blood samples, suggesting a disseminated nature of the mycobacterial disease. Drug susceptibility testing assay, performed on two sequential isolates of the microorganism, showed a pattern of multidrug resistance. Despite aggressive therapy with several antimycobacterial drugs, including clarithromycin, the infection persisted, and the patient died.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11158161      PMCID: PMC87830          DOI: 10.1128/JCM.39.2.816-819.2001

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  19 in total

1.  Rapid identification of mycobacteria to the species level by polymerase chain reaction and restriction enzyme analysis.

Authors:  A Telenti; F Marchesi; M Balz; F Bally; E C Böttger; T Bodmer
Journal:  J Clin Microbiol       Date:  1993-02       Impact factor: 5.948

2.  Mycobacterium abscessus infection in cystic fibrosis. Colonization or infection?

Authors:  A R Cullen; C L Cannon; E J Mark; A A Colin
Journal:  Am J Respir Crit Care Med       Date:  2000-02       Impact factor: 21.405

3.  Brief report: disseminated mycobacteriosis caused by drug-resistant Mycobacterium triplex in a human immunodeficiency virus-infected patient during highly active antiretroviral therapy.

Authors:  A Cingolani; M Sanguinetti; A Antinori; L M Larocca; F Ardito; B Posteraro; G Federico; G Fadda; L Ortona
Journal:  Clin Infect Dis       Date:  2000-07       Impact factor: 9.079

4.  Nontuberculous mycobacteria in adult patients with cystic fibrosis.

Authors:  J M Kilby; P H Gilligan; J R Yankaskas; W E Highsmith; L J Edwards; M R Knowles
Journal:  Chest       Date:  1992-07       Impact factor: 9.410

Review 5.  Nontuberculous mycobacterial pulmonary disease in cystic fibrosis.

Authors:  K N Olivier; J R Yankaskas; M R Knowles
Journal:  Semin Respir Infect       Date:  1996-12

6.  The role of Mycobacteria Other Than Tuberculosis (MOTT) in patients with cystic fibrosis.

Authors:  K Hjelt; N Højlyng; P Howitz; N Illum; E Munk; N H Valerius; K Fursted; K N Hansen; I Heltberg; C Koch
Journal:  Scand J Infect Dis       Date:  1994

7.  Etest for routine clinical antimicrobial susceptibility testing of rapid-growing mycobacteria isolates.

Authors:  F P Koontz; M E Erwin; M S Barrett; R N Jones
Journal:  Diagn Microbiol Infect Dis       Date:  1994-07       Impact factor: 2.803

8.  Activities of four macrolides, including clarithromycin, against Mycobacterium fortuitum, Mycobacterium chelonae, and M. chelonae-like organisms.

Authors:  B A Brown; R J Wallace; G O Onyi; V De Rosas; R J Wallace
Journal:  Antimicrob Agents Chemother       Date:  1992-01       Impact factor: 5.191

9.  Nontuberculous mycobacterial disease in adult cystic fibrosis patients.

Authors:  M L Aitken; W Burke; G McDonald; C Wallis; B Ramsey; C Nolan
Journal:  Chest       Date:  1993-04       Impact factor: 9.410

10.  Identification of clinically significant Mycobacterium fortuitum complex isolates.

Authors:  V A Silcox; R C Good; M M Floyd
Journal:  J Clin Microbiol       Date:  1981-12       Impact factor: 5.948

View more
  77 in total

1.  Clarithromycin resistance to Mycobacterium abscessus.

Authors:  B A Brown-Elliott; R J Wallace
Journal:  J Clin Microbiol       Date:  2001-07       Impact factor: 5.948

Review 2.  Antimicrobial susceptibility testing, drug resistance mechanisms, and therapy of infections with nontuberculous mycobacteria.

Authors:  Barbara A Brown-Elliott; Kevin A Nash; Richard J Wallace
Journal:  Clin Microbiol Rev       Date:  2012-07       Impact factor: 26.132

3.  Vaccine strategies against cystic fibrosis pathogens.

Authors:  Vincent Le Moigne; Jean-Louis Gaillard; Jean-Louis Herrmann
Journal:  Hum Vaccin Immunother       Date:  2016-03-03       Impact factor: 3.452

4.  Value of the chlorhexidine decontamination method for recovery of nontuberculous mycobacteria from sputum samples of patients with cystic fibrosis.

Authors:  Agnès Ferroni; Hoang Vu-Thien; Philippe Lanotte; Muriel Le Bourgeois; Isabelle Sermet-Gaudelus; Brigitte Fauroux; Sophie Marchand; Françoise Varaigne; Patrick Berche; Jean-Louis Gaillard; Catherine Offredo
Journal:  J Clin Microbiol       Date:  2006-06       Impact factor: 5.948

5.  Acute respiratory failure involving an R variant of Mycobacterium abscessus.

Authors:  Emilie Catherinot; Anne-Laure Roux; Edouard Macheras; Dominique Hubert; Moussa Matmar; Luc Dannhoffer; Thierry Chinet; Philippe Morand; Claire Poyart; Beate Heym; Martin Rottman; Jean-Louis Gaillard; Jean-Louis Herrmann
Journal:  J Clin Microbiol       Date:  2008-11-19       Impact factor: 5.948

6.  Demonstration of cord formation by rough Mycobacterium abscessus variants: implications for the clinical microbiology laboratory.

Authors:  Alejandro Sánchez-Chardi; Francesc Olivares; Thomas F Byrd; Esther Julián; Cecilia Brambilla; Marina Luquin
Journal:  J Clin Microbiol       Date:  2011-04-13       Impact factor: 5.948

Review 7.  Clinical significance of microbial infection and adaptation in cystic fibrosis.

Authors:  Alan R Hauser; Manu Jain; Maskit Bar-Meir; Susanna A McColley
Journal:  Clin Microbiol Rev       Date:  2011-01       Impact factor: 26.132

8.  Deciphering and Imaging Pathogenesis and Cording of Mycobacterium abscessus in Zebrafish Embryos.

Authors:  Audrey Bernut; Christian Dupont; Alain Sahuquet; Jean-Louis Herrmann; Georges Lutfalla; Laurent Kremer
Journal:  J Vis Exp       Date:  2015-09-09       Impact factor: 1.355

Review 9.  Nontuberculous mycobacteria: the changing epidemiology and treatment challenges in cystic fibrosis.

Authors:  Janice M Leung; Kenneth N Olivier
Journal:  Curr Opin Pulm Med       Date:  2013-11       Impact factor: 3.155

10.  Importance of T cells, gamma interferon, and tumor necrosis factor in immune control of the rapid grower Mycobacterium abscessus in C57BL/6 mice.

Authors:  Martin Rottman; Emilie Catherinot; Patrick Hochedez; Jean-François Emile; Jean-Laurent Casanova; Jean-Louis Gaillard; Claire Soudais
Journal:  Infect Immun       Date:  2007-09-17       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.